Related Experiment Video

Updated: Aug 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Antiplatelet therapy in ischemic stroke

Endre Pongrácz1, Zoltán Káposzta

  • 1Department of Neurology, Central Hospital, Ministry of Interior Budapest, H-1071 Budapest, Városligeti fasor 9-13, Hungary. epongracz@bm.gov.hu

Expert Review of Neurotherapeutics
|July 20, 2005
PubMed

Insights

Antiplatelet therapy effectively reduces stroke risk. Tailored drug therapy, considering individual factors and laboratory results, is crucial for long-term secondary prevention of ischemic stroke and reducing bleeding risks.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Stroke is a leading cause of death and disability.
  • Atherothrombosis underlies ischemic stroke and vascular death.
  • Antiplatelet therapy is standard for acute stroke and secondary prevention.

Purpose of the Study:

  • To review the efficacy of antiplatelet therapy in stroke prevention.
  • To discuss factors influencing antiplatelet drug dosage and response.
  • To explore future directions in tailored antiplatelet therapy for secondary stroke prevention.

Main Methods:

  • Review of numerous clinical trials and meta-analyses on antiplatelet therapy.
  • Discussion of current antiplatelet agents and their mechanisms.
  • Examination of the correlation between laboratory-measured effects and clinical outcomes.

Main Results:

  • Antiplatelet therapy significantly reduces stroke risk in patients with prior stroke or transient ischemic attack.
  • Individualized dosing is necessary due to genetic and environmental factors affecting drug response.
  • Laboratory-measurable effects correlate with clinical effectiveness in stroke and cardiovascular patients.

Conclusions:

  • Optimizing antiplatelet therapy requires consideration of individual patient variability.
  • Future antiplatelet strategies may involve combination therapy with low dosages to balance efficacy and bleeding risk.
  • Laboratory-controlled, tailored drug therapy is essential for effective long-term secondary prevention of ischemic stroke.

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...